中西医结合研究
中西醫結閤研究
중서의결합연구
RESEARCH OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
6期
286-289
,共4页
杨志勇%万鸿%曹钟%姬生威%陈传喜
楊誌勇%萬鴻%曹鐘%姬生威%陳傳喜
양지용%만홍%조종%희생위%진전희
SOX方案%参芪扶正注射液%晚期胃癌
SOX方案%參芪扶正註射液%晚期胃癌
SOX방안%삼기부정주사액%만기위암
SOX regimen%Shenqifuzheng injection%advanced gastric cancer
目的:研究替吉奥胶囊联合奥沙利铂(SOX方案)联合参芪扶正注射液治疗老年晚期胃癌的临床疗效。方法选择本院2011年1月—2014年1月不宜行手术切除治疗的老年晚期胃癌患者86例,随机分为2组。对照组40例,单用SOX方案化疗,治疗组46例,采用SOX方案联合参芪扶正注射液治疗,比较2组临床疗效及相关不良反应。结果治疗组和对照组总有效率分别为58.7%与35.0%,2组总有效率比较,差异有统计学意义(P<0.05)。治疗前,2组患者血清中糖类抗原199(CA199)、癌胚抗原(CEA)和糖类抗原242(CA242)水平无明显差异;治疗后,2组患者血清中CA199、CEA和CA242均显著低于治疗前(P<0.05,P<0.01),治疗组明显低于对照组(P<0.05)。治疗组相关不良反应明显轻于对照组(P<0.05)。结论SOX方案联合参芪扶正注射液较单用SOX方案治疗晚期胃癌近期疗效明显提高,血清中肿瘤标志物明显降低,不良反应亦显著减轻。
目的:研究替吉奧膠囊聯閤奧沙利鉑(SOX方案)聯閤參芪扶正註射液治療老年晚期胃癌的臨床療效。方法選擇本院2011年1月—2014年1月不宜行手術切除治療的老年晚期胃癌患者86例,隨機分為2組。對照組40例,單用SOX方案化療,治療組46例,採用SOX方案聯閤參芪扶正註射液治療,比較2組臨床療效及相關不良反應。結果治療組和對照組總有效率分彆為58.7%與35.0%,2組總有效率比較,差異有統計學意義(P<0.05)。治療前,2組患者血清中糖類抗原199(CA199)、癌胚抗原(CEA)和糖類抗原242(CA242)水平無明顯差異;治療後,2組患者血清中CA199、CEA和CA242均顯著低于治療前(P<0.05,P<0.01),治療組明顯低于對照組(P<0.05)。治療組相關不良反應明顯輕于對照組(P<0.05)。結論SOX方案聯閤參芪扶正註射液較單用SOX方案治療晚期胃癌近期療效明顯提高,血清中腫瘤標誌物明顯降低,不良反應亦顯著減輕。
목적:연구체길오효낭연합오사리박(SOX방안)연합삼기부정주사액치료노년만기위암적림상료효。방법선택본원2011년1월—2014년1월불의행수술절제치료적노년만기위암환자86례,수궤분위2조。대조조40례,단용SOX방안화료,치료조46례,채용SOX방안연합삼기부정주사액치료,비교2조림상료효급상관불량반응。결과치료조화대조조총유효솔분별위58.7%여35.0%,2조총유효솔비교,차이유통계학의의(P<0.05)。치료전,2조환자혈청중당류항원199(CA199)、암배항원(CEA)화당류항원242(CA242)수평무명현차이;치료후,2조환자혈청중CA199、CEA화CA242균현저저우치료전(P<0.05,P<0.01),치료조명현저우대조조(P<0.05)。치료조상관불량반응명현경우대조조(P<0.05)。결론SOX방안연합삼기부정주사액교단용SOX방안치료만기위암근기료효명현제고,혈청중종류표지물명현강저,불량반응역현저감경。
Objective To observe the clinical efficacy of SOX regimen combined with Shenqifuzheng injection for elderly patients with advanced gastric cancer.Methods Eighty-six patients with unresectable gastric cancer from January 2011 to January 2014 were randomly divided into treatment group and control groups. Forty-six pa-tients of treatment group received SOX regimen combined with Shenqifuzheng injection ,and forty patients of con-trol group were given SOX regimen only. The curative effect and side effect were evaluated. Three kinds of serum tumor markers CA199 ,CEA and CA242 were detected.Results After treatment ,the overall response rate of treat-ment group was 58.7% ,obviously higher than 35.0% in control group(P<0.05).Before treatment ,serum levels of CA199 ,CEA and CA242 were not different between both groups.Serum levels of CA199 ,CEA and CA242 of both groups were significantly reduced when compared with those before treatment (P< 0.05 ,P< 0.01).After treatment ,serum levels of CA199 ,CEA and CA242 in treatment group were much lower than those of control group(P< 0.05).The side effect rate of treatment group was remarkedly lower than that of control group (P<0.05).Conclusion For elderly patients with advanced gastric cancer ,the integrative method of SOX regimen com-bined with Shenqifuzheng injection can improve the short-term clinical efficacy ,reduce the levels of serum tumor markers ,and reduce side effects of chemotherapy ,which is worthy to be applied in clinic widely.